ONCAlert | 2018 ASCO Annual Meeting

Nivolumab in the Adjuvant Setting for Melanoma

Jeffrey S. Weber, MD, PhD
Published Online: 8:48 AM, Fri October 20, 2017


Jeffrey S. Weber, MD, PhD, deputy director and co-director of the Melanoma Program at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center,

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.